• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病患者的血脂异常诊断与治疗被忽视。

Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.

作者信息

Poussa Heikki, Strandberg Timo E, Tikkanen Ilkka, Kauhanen Petteri, Lepäntalo Mauri

机构信息

Department of Surgery, University of Helsinki, Finland.

出版信息

Scand Cardiovasc J. 2007 Jun;41(3):138-41. doi: 10.1080/14017430601187751.

DOI:10.1080/14017430601187751
PMID:17487761
Abstract

OBJECTIVE

Our aim was to investigate how dyslipidemia was diagnosed and treated in patients with peripheral artery disease (PAD) in a university vascular clinic.

DESIGN

Our analysis included all 1 843 PAD patients (median age 71 years, interquartile range 63-79, M/W 975/868) who attended the clinic in 2002-2003 either for diagnostic angiography or for revascularization. The charts of patients tested for dyslipidemia were reviewed closer.

RESULTS

Serum lipids were measured in only 214 PAD patients (11.6%). Of them 37.9% smoked, 59.8% had antihypertensive medication, 35.0% diabetes, and 30.8% a history of coronary heart disease. Mean serum cholesterol concentration was 4.5 mmol/l (SD 1.3), LDL-cholesterol 2.54 (0.48), HDL-cholesterol 1.25 (0.48), and triglycerides 1.62 (0.84). Only 40 patients (19.7%) were using statins, this was increased to 72 (33.6%) after clinic visit. Consequently, 50.0% and 53.2% met the current total cholesterol (<4.5 mmol/l) and LDL-cholesterol (<2.5 mmol/l) goals, respectively.

CONCLUSIONS

Dyslipidemia was highly under-diagnosed among PAD patients. Serum lipids were measured only in a minority and among them serum lipid values and the use of hypolipidemic drugs were not optimal according to guidelines.

摘要

目的

我们的目的是调查在一所大学血管诊所中,外周动脉疾病(PAD)患者的血脂异常是如何被诊断和治疗的。

设计

我们的分析纳入了2002年至2003年到该诊所就诊以进行诊断性血管造影或血管重建的所有1843例PAD患者(中位年龄71岁,四分位间距63 - 79岁,男性/女性975/868)。对接受血脂异常检测的患者病历进行了更仔细的审查。

结果

仅214例(11.6%)PAD患者检测了血脂。其中37.9%吸烟,59.8%服用抗高血压药物,35.0%患有糖尿病,30.8%有冠心病史。平均血清胆固醇浓度为4.5 mmol/l(标准差1.3),低密度脂蛋白胆固醇2.54(0.48),高密度脂蛋白胆固醇1.25(0.48),甘油三酯1.62(0.84)。仅40例患者(19.7%)使用他汀类药物,门诊就诊后这一比例增至72例(33.6%)。因此,分别有50.0%和53.2%的患者达到了目前的总胆固醇(<4.5 mmol/l)和低密度脂蛋白胆固醇(<2.5 mmol/l)目标。

结论

PAD患者中血脂异常的诊断严重不足。仅少数患者检测了血脂,且根据指南,其中血脂值和降脂药物的使用情况并不理想。

相似文献

1
Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.外周动脉疾病患者的血脂异常诊断与治疗被忽视。
Scand Cardiovasc J. 2007 Jun;41(3):138-41. doi: 10.1080/14017430601187751.
2
Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.法国全科医疗中接受降脂治疗患者的混合性血脂异常:一项观察性研究。
Clin Ther. 2007 Aug;29(8):1671-81. doi: 10.1016/j.clinthera.2007.08.003.
3
Impact of international guidelines on the management of cardiovascular risk factors in diabetic patients with peripheral arterial disease.国际指南对糖尿病合并外周动脉疾病患者心血管危险因素管理的影响
Int Angiol. 2009 Jun;28(3):175-80.
4
Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.外周动脉疾病的药物风险因素治疗尚不完善,需要血管外科医生的参与。
Ann Vasc Surg. 2007 Mar;21(2):163-6. doi: 10.1016/j.avsg.2007.01.008.
5
Cholesterol and peripheral vascular disease: a neglected topic?胆固醇与外周血管疾病:一个被忽视的话题?
Scand Cardiovasc J. 2007 Jun;41(3):136-7. doi: 10.1080/14017430701316581.
6
Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents.在当代患有冠心病风险等同症的普通医疗人群中,已接受的血清脂质目标的达成程度。
Am J Cardiol. 2006 Nov 1;98(9):1231-3. doi: 10.1016/j.amjcard.2006.05.057. Epub 2006 Sep 7.
7
Achieving vascular risk factor targets: a survey of a London general practice.实现血管危险因素目标:对伦敦一家全科诊所的调查。
Angiology. 2008 Feb-Mar;59(1):36-46. doi: 10.1177/0003319707309538.
8
Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.基于模型的模拟,以探讨遵循糖尿病和混合性血脂异常患者甘油三酯和低密度脂蛋白胆固醇控制实践指南的成本效益。
Clin Ther. 2009 Apr;31(4):862-79. doi: 10.1016/j.clinthera.2009.04.015.
9
Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).单片氨氯地平/阿托伐他汀有助于不同种族患者实现血压和血脂的推荐目标(双子座-AALA研究)。
J Hum Hypertens. 2009 Mar;23(3):196-210. doi: 10.1038/jhh.2008.114. Epub 2008 Sep 18.
10
Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.瑞士日常实践中当前的心血管风险管理模式,特别关注降脂治疗。
Eur J Cardiovasc Prev Rehabil. 2010 Jun;17(3):363-72. doi: 10.1097/HJR.0b013e328333c1d9.

引用本文的文献

1
Reduced high-density lipoprotein level is linked to worse ankle brachial index and peak oxygen uptake in postmenopausal women with peripheral arterial disease.高密度脂蛋白水平降低与绝经后外周动脉疾病女性的踝臂指数和峰值摄氧量更差相关。
Angiology. 2010 Oct;61(7):698-704. doi: 10.1177/0003319710369100. Epub 2010 Jun 7.